Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inIOncology

Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Posted by By Ren Jiamo 2025.07.01Posted inIOncology0 Shares
Home » Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer
YouTube player
Post Views: 3,421

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2025.07.03
Ren Jiamo
View All Posts

Post navigation

Previous Post
Early research, clinical practice and thinking of innovative NK cell therapy Early research, clinical practice and thinking of innovative NK cell therapy
Next Post
Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
Media Medic Publishing Company Limited(HK)
赛美出版有限公司（香港）
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied